Presenters at this year's meeting of the American Academy of Neurology (AAN), held in Seattle April 2–7, reported the latest research in neurology. NEJM Group covered the meeting, with guidance from Teshamae Monteith, MD, and NEJM Journal Watch Neurology Associate Editor Seemant Chaturvedi, MD. Here are some highlights of that coverage.
≤4 Monthly Headache Days May Be Useful Target in Chronic Migraine
Achieving four or fewer headache days per month may be a useful goal for patients with chronic migraine, according to a post hoc analysis from the industry-supported PROMISE-2 trial.
In the trial, nearly 1100 adults with chronic migraine were randomized to receive two doses of preventive treatment with intravenous eptinezumab or placebo 12 weeks …